23 completed. 23 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 23 | Completed 23 |
| Phase 2 | 9 | Completed 9 |
Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Healthy Volunteer Burn Therapy Study cNP8, Placebo - Burns | Phase 1 | Completed | Neomatrix Therapeutics, Inc. | 32 | 2024-01-30 | 2024-11-14 |
| Safety of Extracellular Vesicles for Burn Wounds AGLE-102 - Burns | Phase 1 | Completed | Aegle Therapeutics | 1 | 2023-08-10 | 2024-11-20 |
| Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds realSKIN (skin xenotransplant), Human Cadaver Allograft - Deep Full-thickness Burn Injury (Disorder) | Phase 1 / Phase 2 | Completed | XenoTherapeutics, Inc. | 25 | 2019-03-15 | 2024-01-12 |
| Treatment of Patients With Skin Burns Using Keratinocytes and Skin Fibroblasts Fibroblasts and keratinocytes - Burns | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 12 | 2017-01-01 | 2020-07-24 |
| Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes Dexmedetomidine - Anxiety, Burns | Phase 1 / Phase 2 | Completed | Ohio State University | 20 | 2015-04-01 | 2023-04-14 |
| A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound ALLO-ASC-DFU - Burn | Phase 1 | Completed | Anterogen Co., Ltd. | 5 | 2015-03-01 | 2015-12-30 |
| Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study Tobramycin - Burns, Infection | Phase 1 / Phase 2 | Completed | Sandra Walker | 10 | 2015-03-01 | 2015-12-14 |
| Stem Cell Therapy to Improve Burn Wound Healing Allogeneic (MSC's) Application to the Burn Wounds - Skin Burn Degree Second | Phase 1 | Completed | E.Badiavas | 15 | 2014-06-04 | 2020-04-30 |
| Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects denovoDerm, denovoSkin - Burn Injury, Soft Tissue Injury | Phase 1 | Completed | University of Zurich | 12 | 2014-05-01 | 2021-09-08 |
| The Sun Protective Effect of Melatonin Melatonin - Sunburn | Phase 1 | Completed | Herlev Hospital | 22 | 2013-05-01 | 2013-08-29 |
| StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns StrataGraft Skin Tissue - Skin Wound, Burns | Phase 1 | Completed | Stratatech, a Mallinckrodt Company | 30 | 2011-09-01 | 2019-10-16 |
| Burn Micronutrient Repletion Pilot Study Vitamin and Mineral supplementation - Burn | Phase 1 | Completed | Southern Illinois University | 28 | 2010-08-01 | 2015-08-26 |
| Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Procellera (Bioelectric Wound Dressing), Opsite (Transparent Adhesive Dressing) - Burns, Wound Healing | Phase 1 / Phase 2 | Completed | Vomaris Innovations | 17 | 2009-09-01 | 2010-12-10 |
| Clinical Evaluation of PoreSkin PoreSkin - Treatment | Phase 1 | Completed | Chulalongkorn University | 11 | 2009-09-01 | 2015-07-01 |
| Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation Placebo gel, GLYC-101 gel (1.0 %) - Wounds | Phase 1 / Phase 2 | Completed | TR Therapeutics | 12 | 2008-03-01 | 2021-10-28 |
| Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels rhu-pGelsolin, Placebo - Low Gelsolin, Trauma | Phase 1 / Phase 2 | Completed | Critical Biologics Corporation | 40 | 2008-03-01 | 2010-09-29 |
| Computer Decision Support to Achieve Glycemic Control in the ICU Endo Tool - Burns, Hypoglycemia | Phase 1 | Completed | United States Army Institute of Surgical Research | 24 | 2008-01-01 | 2015-09-03 |
| A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity Doxycycline, Voriconazole - Healthy Volunteers, Fungal Infections | Phase 1 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 62 | 2007-05-25 | 2026-10-13 |
| StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects StrataGraft Skin Tissue, Cadaver allograft - Third Degree Burn, Burns | Phase 1 / Phase 2 | Completed | Stratatech, a Mallinckrodt Company | 15 | 2006-07-01 | 2019-10-16 |
| Evaluation Of Linezolid Pk Profile In Burns Patients linezolid - Burns | Phase 1 | Completed | Pfizer | 16 | 2006-05-01 | 2009-07-14 |
Showing 20 of 23. Sign in to see all of them.
Wounds and Injuries (4) · Infections (2) · Sunburn (2) · Anxiety Disorders (1) · Bacterial Infections (1) · Bone Demineralization, Pathologic (1) · Cicatrix (1) · Degloving Injuries (1) · Erythema (1) · Hyperglycemia (1) · Hypoglycemia (1) · Meretoja syndrome (1) · Mycoses (1) · Necrosis (1)
Wounds and Injuries (19) · Pathological Conditions, Signs and Symptoms (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Infections (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Photosensitivity Disorders (2) · Bacterial Infections and Mycoses (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Digestive System Diseases (1) · Fibrosis (1)
Cholecalciferol (1) · Dexmedetomidine (1) · Doxycycline (1) · Ergocalciferols (1) · Fibrin Tissue Adhesive (1) · Linezolid (1) · Melatonin (1) · Thrombin (1) · Tobramycin (1) · Vitamins (1) · Voriconazole (1)
Stratatech, a Mallinckrodt Company (2) · Aegle Therapeutics (1) · Anterogen Co., Ltd. (1) · Baxter Healthcare Corporation (1) · Centre Hospitalier Universitaire Vaudois (1) · Chulalongkorn University (1) · Critical Biologics Corporation (1) · E.Badiavas (1) · Herlev Hospital (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Neomatrix Therapeutics, Inc. (1) · Ohio State University (1) · Pfizer (1) · Sandra Walker (1)
United States (14) · Switzerland (2) · Belarus (1) · Canada (1) · Denmark (1) · France (1) · Hong Kong (1) · South Korea (1)
Alexey Chasnoit, Dr (1) · Andrew L Blount, MD (1) · Arnold Luterman, MD (1) · Carl Schulman, MD (1) · Carl Schulman, MD, PhD (1) · Cecilie Scheuer, Research Scholar (1) · Daniel Lozano, MD (1) · David G. Greenhalgh, MD (1) · David Herndon, MD (1) · Elizabeth A Mann, RN, MSN (1) · Glenn D. Warden, MD (1) · Heidi H Kong, M.D. (1) · Igor Volotovski, Prof (1) · Jeremy Goverman, MD (1)
PMID 11525858, PMID 11753055, PMID 12694482, PMID 12890465, PMID 15175591, PMID 15269581, PMID 17356164, PMID 17960651, PMID 19276766, PMID 21475006, PMID 28602587, PMID 33305842, PMID 39115183, PMID 40407357, PMID 8454661, PMID 9852660
R44AR047499 (1)